About Me
A Professor of Physiology and Pathophysiology, Andrew is an internationally recognized authority in the pathobiology of chronic lung disease, contributing seminal work that shows how smooth muscle and fibroblasts can contribute to asthma pathogenesis, paving the way for novel therapies. He is a renowned regional, national and international leader, launching research networks, developing a National Respiratory Research Strategy and a multidisciplinary training and career development program for the Canadian Lung Association. He is the second ever PhD President of the Canadian Thoracic Society, and was elected to the Board of Directors of the American Thoracic Society.